Advertisement

The role of IgA in the immunopathogenesis of rheumatoid arthritis

  • D. R. Stanworth

Abstract

It is now widely accepted that immunological responses play a significant role in the pathogenesis of rheumatoid arthritis.

Keywords

Rheumatoid Arthritis Rheumatoid Arthritis Patient Joint Fluid Rheumatoid Patient Monoarticular Arthritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Geiler, G. (1976). Proliferative and exudative features of the rheumatoid synovium. In Dumonde, D.C. (ed.). Infection and Immunology in the Rheumatic Diseases. Chapter 50, pp. 413–16. (Oxford: Blackwell)Google Scholar
  2. 2.
    Geiler, G. (1971). The antibody synthesis of the synovial membrane in rheumatoid arthritis. In Mullen, W., Harweth, H.G. and Fehr, K. (eds.). Rheumatoid Arthritis, pp. 317–23. (New York, London: Academic Press)Google Scholar
  3. 3.
    Winchester, R.J., Agnello, V. and Kunkel, H.G. (1970). Gammaglobulin complexes in synovial fluids of patients with rheumatoid arthritis. Clin. Exp. Immunol., 6, 689–706PubMedGoogle Scholar
  4. 4.
    Winchester, R.J., Kunkel, H.G. and Agnello, V. (1971). Occurrence of γ-globulin complexes in serum and joint fluid of rheumatoid patients; use of monoclonal rheumatoid factors in reagents for their demonstration. J. Exp. Med., 134, 286s–295sPubMedGoogle Scholar
  5. 5.
    Pope, R.M., Teller, D.C. and Mannik, M. (1971). Association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA, 71, 517–21CrossRefGoogle Scholar
  6. 6.
    Stanworth, D.R. (1985). Immunoglobulinopathies. In Gynn, L.E. and Steward, M.W. (eds.). Antibody Production, pp. 183–231. (New York, Chichester: John Wiley)Google Scholar
  7. 7.
    Lamm, M.E. (1976). Cellular aspects of immunoglobulin A. Adv. Immunol., 22, 223–90PubMedCrossRefGoogle Scholar
  8. 8.
    Stanworth, D.R., Johns, P., Felix-Davis, D.D. and Wilkinson, B.R. (1976). The effect of long term D-penicillamine treatment on serum immunoglobulin and antibody levels in rheumatoid arthritis. In Munthe, E. (ed.). Penicillamine Research in Rheumatoid Disease. (Proceedings Symposium at Spåtind, Norway), pp. 132–45. (Oslo: Fabritius & Sønner)Google Scholar
  9. 9.
    Hrnčiř, Z. and Tichý, M. (1978). Subclasses IgAl and IgA2 in serum and synovial fluid in rheumatoid arthritis and reactive synovitis of local origin. Ann. Rheum. Dis., 37, 518–22PubMedCrossRefGoogle Scholar
  10. 10.
    Conley, M.E., Chan, M.A. and Sigal, N.H. (1987). In vitro regulation of IgA sub-class production. III Selective transformation of IgA1 producing cells by Epstein-Barr virus. J. Immunol., 138, 1403–7PubMedGoogle Scholar
  11. 11.
    Moller, F., Strom, H. and Al-Balaghi, S. (1980). Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases (editorial). Scand. J. Immunol., 12, 177–82PubMedCrossRefGoogle Scholar
  12. 12.
    Dammacco, F., Tursi, A., Luciuero, G. and Bonomo, L. (1976). Selective IgA deficiency: a heterogenous immunodeficiency syndrome. Ric. Clin. Lab. 6 (Suppl. 3), 45–55Google Scholar
  13. 13.
    Fontana, A., Sauter, R., Grob, P.J. and Joller, H. (1976). IgA deficiency, epilepsy and hydantoin medication. Lancet, ii, 228–30Google Scholar
  14. 14.
    Strickland, G.T. and Leu, M.L. (1975). Wilson’s disease. Clinical and laboratory manifestations in 40 patients. Medicine, 54, 113–37PubMedGoogle Scholar
  15. 15.
    Stanworth, D.R., Johns, P., Williamson, N., Shadforth, M., Felix-Davis, D. and Thompson, R. (1977). Drug-induced IgA deficiency in rheumatoid arthritis. Lancet, 1, 1001–2PubMedCrossRefGoogle Scholar
  16. 16.
    Johns, P., Felix-Davies, D.D., Hawkins, L.F., Mackintosh, P., Shadforth, M.F., Stanworth, D.R., Thompson, RA. and Williamson, N. (1978). IgA deficiency in patients with rheumatoid arthritis treated with d-penicillamine or gold. Ann. Rheum. Dis., 37, 289. (Abstract)Google Scholar
  17. 17.
    Delamere, J.P., Grindulis, K. and Fair, M. (1983). Effects on rheumatoid activity of drug-induced changes in serum immunoglobulins: particularly selective IgA deficiency. Arthr. Rheum. Dis., 42, 231 (Abstract)Google Scholar
  18. 18.
    Mbuyi-Muamba, W., Stevens, E. and Dequeker, J. (1981). Good response to d-penicillamine in a IgA-deficient rheumatoid patient. Scand. J. Rheumatol., 10, 31–2PubMedGoogle Scholar
  19. 19.
    Stanworth, D.R. (1982). D-penicillamine-induced immunodeficiency. In Dawkins, R.L., Christiansen, F.Z. and Zilko, P.J. (eds.) Immunogenetics in Rheumatology: Musculoskeletal Disease and D-pencillamine. Chapter 8–20, pp. 358–61. (Amsterdam: Excerpta Medica Congress Series 602)Google Scholar
  20. 20.
    Petty, R.E., Palmer, N.R. and Cassidy, Y.J.T. (1979). The association of auto-immune diseases and anti-IgA antibodies in patients with selective IgA deficiency. Clin. Exp. Immunol., 37, 83–8PubMedGoogle Scholar
  21. 21.
    Cowling, P., Ebringer, R. and Ebringer, A. (1984). Association of inflammation with raised serum IgA in ankylosing spondylitis. Ann. Rheum. Dis., 39, 545–9CrossRefGoogle Scholar
  22. 22.
    Grandfors, K. and Toivanen, A. (1986). IgA anti-yersinia antibodies in Yersinia triggered reactive arthritis. Ann. Rheum. Dis., 45, 561–5CrossRefGoogle Scholar
  23. 23.
    Parke, A.L. and Hughes, G.R.V. (1981). Rheumatoid arthritis and food: a case study. Br. Med. J., 282, 2027–29CrossRefGoogle Scholar
  24. 24.
    Stanworth, D.R. (1985). The role of IgE and IgA in rheumatoid arthritis. Hungarian Rheumatol Suppl., Proc. EULAR Symp. on Current Immunological Concepts in Rheumatology — Immunopathology, Genetics and Therapy, Budapest, Sept. 1984, pp. 9–16Google Scholar
  25. 25.
    Withrington, R.H., Teitsson, I., Valdimarsson, H. and Seifert, M.H. (1984). Prospective study of eary rheumatoid arthritis. 2. Association of rheumatoid factor isotypes with fluctuations in disease activity. Ann. Rheum. Dis., 43, 678-85Google Scholar
  26. 26.
    Jans, H., Halberg, P. and Lorenzen, I. (1983). Circulating immune complexes in rheumatoid arthritis with extra-articular manifestations. Scand. J. Rheumatol., 12, 215–18PubMedCrossRefGoogle Scholar
  27. 27.
    Westedt, M.L., Daha, M.R, Baldwin, W.M., Stijnen, T. and Cats, A. (1986). Serum immune complexes containing IgA appear to predict erosive arthritis in a longitudinal study in rheumatoid arthritis. Ann. Rheum. Dis., 45, 809–15PubMedCrossRefGoogle Scholar
  28. 28.
    Egido, J., Sancho, J., Rivera, F. and Sanchez-Cresdo, M. (1982). Handling of soluble IgA aggregates by the mononuclear phagocytic system in mice. A comparison with IgG aggregates. Immunology, 46, 1–7PubMedGoogle Scholar
  29. 29.
    Laurell, C.B. and Thulin, E. (1975). Complexes in human plasma between α1-antitrypsin and IgA1 and α1-antitrypsin and fibrinogen. Scand. J. Immunol., 4, (Suppl. 2), 7–12CrossRefGoogle Scholar
  30. 30.
    Tomasi, T. and Hauptman, S. (1974). The binding of trypsin to human IgA. J. Immunol., 112, 2274–7PubMedGoogle Scholar
  31. 31.
    Stanworth, D.R. (1981). The effect of d-penicillamine treatment on humoral immunological factors in clinical and experimental arthritis. In Maini, R.N. and Berry, H. (eds.). Modulation of Autoimmunity and Disease: the Penicillamine Experience, pp. 31–35 (New York: Praeger)Google Scholar
  32. 32.
    Laurell, C.B., Grubb, A. and Thulin, E. (1976). J Chain and α1-antitrypsin — IgA complexes in sera with polyclonal and monoclonal IgA. Ric. Clin. Lab., 6 (Suppl. 3), 57–67Google Scholar
  33. 33.
    Stanworth, D.R., Lewin, I. and Crockson, R.A. (1985). Measurement of IgA-α1-antitrypsin (α1AT) complex in the sera of patients with IgA myelomatosis. Immunol. Lett., 11, 277–80PubMedCrossRefGoogle Scholar
  34. 34.
    Carrell, R.W., Jeppsson, J.V., Laurell, C.B., Brennon, S.W., Owen, M.C., Vaughan, L. and Boswell, D.R. (1982). Structure and variation of human α1-antitrypsin. Nature, 298, 329–33PubMedCrossRefGoogle Scholar
  35. 35.
    Stanworth, D.R.(1985). IgA dysfunction in rheumatoid arthritis. Immunol Today, 6, 43–5CrossRefGoogle Scholar
  36. 36.
    Wolheim, FA., Jeppson, J.O. and Laureil, C.B. (1976). Plasma antitrypsin—IgA complexes, plasma cysteine and urinary cysteine penicillamine disulphide excretion: correlation with responsiveness to penicillamine in rheumatoid arthritis. In Munthe, F. (ed.). Pencillamine in Rheumatic Diseases: Mode of Action. A Key to Pathogenesis, pp. 152–60. (Oslo: Fabritius & Sønner)Google Scholar
  37. 37.
    Dawes, P.T., Jackson, R., Shadforth, M.F., Lewin, I. and Stanworth, D.R. (1987). The relationship between the complex of immunoglobulin A and alpha-1-anti-trypsin; its constituent components and the acute phase response as measured by C-reactive protein in rheumatoid arthritis treated with gold or d-penicillamine. Br. J. Rheumatol, 26, 351–3PubMedCrossRefGoogle Scholar
  38. 38.
    Dawes, P.T., Lewin, I. and Stanworth, D.R. (1987). The relationship between the serum and synovial fluid levels of IgA-α1 anti-trypsin (AT) complex with ESR in patients with rheumatoid arthritis. (In preparation)Google Scholar
  39. 39.
    Struthers, G.R., Lewin, I., Bacon, P.A. and Struthers, G.R. (1987). IgA-α1 antitrypsin complexes in ankylosing spondylitis. (In preparation)Google Scholar
  40. 40.
    Stanworth, D.R., Lewin, I.V., Bell, A.L., Boyd, M.W.J, and Haire, M. (1987). A study of the value of measurement of IgA-α1-antitrypsin complex as an index of response to treatment in rheumatoid arthritis. (In preparation)Google Scholar
  41. 41.
    Stanworth, D.R., Lewin, I.V. and Cooper, P. H. (1987). Preliminary observations on a simplified rabbit model of arthritis. (In preparation)Google Scholar
  42. 42.
    Riches, D.W.H. and Stanworth, D.R. (1981). Studies on the possible involvement of complement component C3 in the initiation of acid hydrolase secretion by macrophages. 1. Correlation between enzyme-releasing and complement-activating capacities of several secretagogues. Immunology, 44, 29–39PubMedGoogle Scholar
  43. 43.
    Wilton, J.M.A. (1978). Suppression by IgA of IgG-mediated phagocytosis by human polymorphonuclear leucocytes. Clin. Exp. Immunol., 74, 423–8Google Scholar
  44. 44.
    Van Epps, D.E., Reed, K. and Williams, R.C. (1978). Suppression of human PMN bactericidal activity by human IgA paraproteins. Cell. Immunol., 36, 363–76PubMedCrossRefGoogle Scholar
  45. 45.
    Van Epps, D.E. and Williams, R.C. (1977). Suppression of leukocyte Chemotaxis by human IgA myeloma components. J. Exp. Med., 144, 1227–42CrossRefGoogle Scholar
  46. 46.
    Hunneyball, I.M. and Stanworth, D.R. (1981). Immunological models of rheumatoid arthritis with particular reference to the rabbit. IRCS J. Med. Sci., 9, 1–4Google Scholar
  47. 47.
    Dumonde, D.C. and Glynn, L.E. (1962). The production of arthritis in rabbits by an immunological reaction to fibrin. Br. J. Exp. Pathol., 43, 373–83PubMedGoogle Scholar
  48. 48.
    Hunneyball, I.M., Stewart, C.A. and Stanworth, D.R. (1979). Effect of oral d-penicillamine treatment in experimental arthritis and associated immune responses in rabbits. III Reduction of the monoarticular arthritis. Ann. Rheum. Dis., 38, 271–8PubMedCrossRefGoogle Scholar
  49. 49.
    Hunneyball I.M. and Stanworth, D.R. (1983). The successful use of asialylated IgG as an immunogen and arthritogen in the rabbit. Immunology, 49, 511–18PubMedGoogle Scholar
  50. 50.
    Hunneyball, I.M., Stewart, G.A. and Stanworth, D.R. (1978). The effects of oral d-penicillamine in experimental arthritis and the related response in rabbits. I. The effect on humoral parameters. Immunology, 34, 1053–61PubMedGoogle Scholar
  51. 51.
    Hunneyball, I.M., Stewart, G.A. and Stanworth, D.R. (1977). Effect of d-penicillamine on chronic experimental arthritis in rabbits. Ann. Rheum. Dis., 36, 378–80PubMedCrossRefGoogle Scholar
  52. 52.
    Hopkins, S.J., Freemont, A.J. and Jayson, M.I.V. (1984). Pristane-induced arthritis in Balb/c mice. I. Clinical and histological features of the arthropathy. Rheumatol. Int., 5, 21–8PubMedCrossRefGoogle Scholar
  53. 53.
    Brackertz, D.M., Tchell, G.F., Vadas, M.A., Mackay, LR. and Miller, J.F.A.P. (1977). Studies on antigen-induced arthritis in mice. II Immunological correlates of arthritis susceptibility in mice. J. Immunol., 118, 1639–44PubMedGoogle Scholar
  54. 54.
    Hunneyball, I.M., Crossley, MJ. and Spowace, M. (1986). Studies on the effects of pharmacological agents on antigen-induced arthritis in Balb/c mice. Proc. Int. Symp. on Anti-rheumatics, analgesics and immunomodulators. Monte Carlo, March 1986. Abstract 267Google Scholar
  55. 55.
    Stanworth, D.R., Lewin, I.V. and Hunneyball, I.M. (1987). Studies of the effect of IgA-α1AT complex on biochemical and functional parameters of bone marrow-derived mouse macrophages in vitro. (In preparation)Google Scholar
  56. 56.
    Al-Balaghi, S., Strom, H. and Moller, E. (1985). Effect of drug therapy on circulating and synovial fluid Ig-secreting cells in rheumatoid arthritis. Ann. Rheum. Dis., 44, 232–8PubMedCrossRefGoogle Scholar
  57. 57.
    Fagerhol, M.K. and Cox, D.W. (1981). The Pi polymorphism: genetic, biochemical and clinical aspects of human α1-antitrypsin. Adv. Hum. Genet., 6, 1–62Google Scholar
  58. 58.
    Parekh, R.B., Dwek, R.P., Sutton, R.J., Fernandes, D.L., Leung, A., Stanworth, D.R., Rademacher, T.W., Mizuochi, T., Taniguchi, T., Matsuta, K., Takeuchi, T., Nagano, Y., Miyamoto, T. and Kobata, A. (1985). Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature, 316, 452–7PubMedCrossRefGoogle Scholar
  59. 59.
    Roth, A.R. and Koshland, M.E. (1981). Identification of a lymphocyte enzyme that catalyses pentamer immunoglobulin M assembly. J. Biol. Chem., 256, 4633–9PubMedGoogle Scholar
  60. 60.
    Lorber, A., Pearson, C.M., Meredith, W.L. and Granta-Mandell, L.F. (1964). Serum sulphydryl determination and significance in connective tissue diseases. Ann. Intern. Med., 61, 423–34PubMedGoogle Scholar
  61. 61.
    Walz, D.T. and Dimartino, M.J. (1972). Effect of anti-arthritic drugs in sulphydryl reactivity in rat serum. Proc. Soc. Exp. Biol. Med., 140, 263–8PubMedGoogle Scholar
  62. 62.
    Hall, N.D., Blake, D.R. and Bacon, P.A. (1981). The significance of serum sulphydryl measurements in patients with rheumatoid arthritis treated with d-penicillamine. In Maini, R.N. and Berry, H. (eds.). Modulation of Autoimmunity and Disease: the Pencillamine Experience. pp. 143–9 (Praeger)Google Scholar
  63. 63.
    Drury, P.L., Rudge, S.R. and Perrett, D. (1984). Structural requirements for activity of certain ‘specific’; anti-rheumatic drugs: more than a simple thiol group? Br. J. Rheumatol., 23, 100–06PubMedCrossRefGoogle Scholar

Copyright information

© MTP Press Limited 1988

Authors and Affiliations

  • D. R. Stanworth

There are no affiliations available

Personalised recommendations